Key result
Mitochondrial CaMKII inhibition protects mice against post-MI LV dilation, while overexpression drives severe dilated cardiomyopathy.
Why the study?
Little is known about upstream signals responsible for remodeling myocardial metabolism after pathological stress, despite clear associations between myocardial injury, heart failure, and depressed energetics.
Does genetic mitochondrial CaMKII inhibition prevent left ventricular dilation and dysfunction in mice after myocardial infarction?
Does genetic mitochondrial CaMKII inhibition prevent left ventricular dilation and dysfunction in mice after myocardial infarction?
Mitochondrial CaMKII inhibition protects against adverse structural remodeling and left ventricular dilation after myocardial infarction in mice, highlighting a novel therapeutic target for heart failure.
No takes yet. Share an insight, caveat, or question.
Mitochondrial CaMKII merits testing as a post-MI target; leaves open whether inhibition prevents human remodeling.
Luczak et al. (2020) studied Dilated cardiomyopathy and myocardial infarction. Mitochondrial CaMKII inhibition (mtCaMKIIN) or overexpression (mtCaMKII) vs. Wild-type (WT) littermates or sham surgery was evaluated. Mice with genetic mitochondrial CaMKII inhibition were protected from left ventricular dilation after myocardial infarction, while mitochondrial CaMKII overexpression caused severe dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: